During the last session, Microbot Medical Inc. (NASDAQ:MBOT)’s traded shares were 3.56 million, with the beta value of the company hitting 3.17. At the end of the trading day, the stock’s price was $1.91, reflecting an intraday loss of -12.79% or -$0.28. The 52-week high for the MBOT share is $6.33, that puts it down -231.41 from that peak though still a striking 47.64% gain since the share price plummeted to a 52-week low of $1.00. The company’s market capitalization is $14.29M, and the average intraday trading volume over the past 10 days was 21.36 million shares, and the average trade volume was 3.43 million shares over the past three months.
Microbot Medical Inc. (MBOT) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 2.00. MBOT has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.28.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
Microbot Medical Inc. (NASDAQ:MBOT) trade information
Microbot Medical Inc. (MBOT) registered a -12.79% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -12.79% in intraday trading to $1.91 this Wednesday, 05/24/23, hitting a weekly high. The stock’s 5-day price performance is 60.50%, and it has moved by 25.66% in 30 days. Based on these gigs, the overall price performance for the year is -60.86%. The short interest in Microbot Medical Inc. (NASDAQ:MBOT) is 81010.0 shares and it means that shorts have 0.89 day(s) to cover.
The consensus price target of analysts on Wall Street is $8.00, which implies an increase of 76.12% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $8.00 and $8.00 respectively. As a result, MBOT is trading at a discount of -318.85% off the target high and -318.85% off the low.
Microbot Medical Inc. (MBOT) estimates and forecasts
Yet analysts are ramping up their growth forecast for the fiscal year 2023. Revenue is predicted to grow 42.90% this quarter and then jump 57.10% in the quarter after that.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 12.20%. While earnings are projected to return -14.00% in 2023.
MBOT Dividends
Microbot Medical Inc. is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Microbot Medical Inc. (NASDAQ:MBOT)’s Major holders
Microbot Medical Inc. insiders own 2.98% of total outstanding shares while institutional holders control 28.77%, with the float percentage being 29.66%. Armistice Capital, LLC is the largest shareholder of the company, while 36 institutions own stock in it. As of Mar 30, 2023, the company held over 0.6 million shares (or 7.38% of all shares), a total value of $1.25 million in shares.
The next largest institutional holding, with 0.26 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 3.21% of outstanding shares. At the market price on Mar 30, 2023, these shares were valued at $0.54 million.
Also, the Mutual Funds coming in first place with the largest holdings of Microbot Medical Inc. (MBOT) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. Data provided on Dec 30, 2022 indicates that Vanguard Total Stock Market Index Fund owns about 0.15 million shares. This amounts to just over 1.89 percent of the company’s overall shares, with a $0.46 million market value. The same data shows that the other fund manager holds slightly less at 0.11 million, or about 1.39% of the stock, which is worth about $0.34 million.
